Check-Cap Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Check-Cap Ltd
Access all reports
Check-Cap Ltd. is a medical diagnostics company focused on the development of capsule-based screening technology aimed at detecting colorectal cancer in its early stages. The company's primary product is the C-Scan system, which utilizes a non-invasive, patient-friendly capsule that scans the inner lining of the colon using ultra-low-dose X-rays. This system generates detailed 3D maps of the colon's contours, allowing physicians to identify precancerous polyps and other abnormalities without the need for traditional bowel preparation or invasive procedures. The technology aims to improve patient compliance with colorectal cancer screening protocols globally. The company is headquartered in Isfiya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
CHEK
Country
🇺🇸 United States